Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis

Author(s):
Bergstra, S.A. (0000-0002-7136-5248); Allaart, C.F.; Berg, R. van den; Chopra, A.; Govind, N.; Huizinga, T.W.J. (0000-0001-7033-7520); Landewe, R.B.M.
Published
2017
Publication type
Article / Letter to editor
Rheumatoid arthritisMethotrexateDoseOutcome measuresCombination therapy
Date issued
2017-11-22
Language
English
Is part of
Arthritis Research and Therapy
hdl
1887/115767
doi
10.1186/s13075-017-1468-9